Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Cardiomyopathies

Circulation

Volumn 109, Issue 12, 2004, Pages 1445-1447

  Fontaine, Guy ^a   Prost Squarcioni, Catherine ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Arrhythmia; Cardiomyopathy; Cardioversion; Defibrillation; Focused Perspectives

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE; SOTALOL;

ANTIARRHYTHMIC ACTIVITY; CLINICAL TRIAL; DEFIBRILLATOR; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FIBROSIS; HEART VENTRICLES; HUMANS; SYNDROME; TERMINOLOGY; TREATMENT OUTCOME;

EID: 1842434388     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000121322.91189.2E     Document Type: Review

References (21)

1. Wichter T, Paul M, Wollmann C, et al. Implantable cardioverter/ defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation. 2004;109:1503-1508.
2. Fontaine G, Fontaliran F, Frank R. Arrhythmogenic right ventricular cardiomyopathies: clinical forms and main differential diagnoses. Circulation 1998;97:1532-1535.
3. Marcus FI, Fontaine G, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 cases. Circulation. 1982;65:384-399.
4. Fontaine G, Guiraudon G, Frank R, et al. Stimulation studies and epicardial mapping in ventricular tachycardia: study of mechanisms and selection for surgery. In: Kulbertus HE, ed. Re-entrant Arrhythmias: Mechanisms and Treatment. Baltimore, Md: University Park Press; 1977:334-350.
5. Mallar Z, Tedgui A, Fontaliran F, et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 1996;335:1190-1196.
6. Fontaine G, Fornes P, Hebert JL, et al. Ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathies. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 3rd ed. Philadelphia, Pa: W.B. Saunders; 2003. In press.
7. McKoy G, Protonotarios N, Crosby A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet. 2000;355:2119-2124.
8. Norgett EE, Hatsell SJ, Carvajal-Huerta L, et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet. 2000;9:2761-2766.
9. Rampazzo A, Nava A, Malacrida S, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2002;71:1200-1206.
10. Tiso N, Stephan DA, Nava A, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001;10:189-194.
11. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol. 1992;20:1391-1396.
12. Belhassen B, Viskin S, Fish R, et al. Effects of electrophysiologic-guided therapy with class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol. 1999;10:1313-1315.
13. Fontaine G, Piot O, Sohal PS, et al. Sus-decalage du segment ST en derivations precordiales droites et mort subite: relation avec la dysplasie ventriculaire droite arythmogene. [ST segment elevation in right precordial leads and sudden death: relation with arrhythmogenic right ventricular dysplasia.] Arch Mal Coeur. 1996;89:1323-1329.
14. Haissaguerre M, Shoda M, Jais P, et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation. 2002;106:962-967.
15. Boutitie F, Boissel JP, Connolly SJ, et al. Amiodarone interaction with beta-blockers: analysis of the merged EMIAT and CAMIAT databases. Circulation. 1999;99:2268-2275.
16. Turrini P, Corrado D, Basso C, et al. Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation. 2001;103:3075-3080.
17. Hebert JL, Chemla D, Gerard O, et al. Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia. Am J Cardiol. 2004. In press.
18. Corrado D, Fontaine G, Marcus FI, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Circulation. 2000;101:e101-e106.
19. A Multidisciplinary Study of Right Ventricular Dysplasia. Available at: http://www.arvd.org. Accessed February 26, 2004.
20. Johns Hopkins Medicine. Arrhythmogenic Right Ventricular Dysplasia. Available at: http://www.arvd.com. Accessed February 26, 2004.
21. ARVC/D Clinical Registry Database-Homepage. Available at: http://anpat.unipd.it/ARVC. Accessed February 26, 2004.